Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

TeneoBio

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Newark, California, United States Founded 2009 1-10 employees For Profit

TeneoBio is a biotechnology company that specializes in the development of human heavy chain antibodies.

TeneoBio on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

TeneoBio was acquired by Amgen in 2021 for $900M.
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
14

About TeneoBio

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
12

Company Info

Founded
2009
Employees
1-10
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
17
HQ
Newark, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast
Exit date
Jul 27, 2021

Signals & Scores

Heat score
Low
Trend (7d)
-0.2
Trend (30d)
-0.3
Trend (90d)
-0.1

TeneoBio Funding Rounds

2 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–2 of 2Show
Page 1 / 1

TeneoBio Key People

CEO
14
professional contacts at TeneoBio
Contact execs at TeneoBio

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to TeneoBio

Loading news…

FAQs about TeneoBio

People who checked this page also checked these

Browse the full Acquirezy directory.